LCC Advances in ALK+ Cancer in Cantonese

Lung Cancer Considered by Lung Cancer Considered

Aug 14, 202600:46:26Science & Medicine

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with Dr. Tony Mok, Dr. Chao Zhang, and Dr. Wen-Zhao Zhong. The discussion reviews...

Related Episodes

Continue listening to more episodes from Lung Cancer Considered.

Before You Go: A Practical Guide to WCLC 2026 in Seoul

Sep 4, 2026 - 00:38:27

Get ready for WCLC 2026 in Seoul with Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Florez...

Beyond Stage IV: Rethinking Oligometastatic Lung Cancer

Sep 1, 2026 - 00:47:30

In this episode, Dr. Narjust Florez is joined by Dr. Yasir Elamin and Dr. Liliana Faroni to explore the e...

LCC in Korean: The Role of Immunotherapy in Lung Cancer

Aug 28, 2026 - 00:46:42

In this Korean-language episode of Lung Cancer Considered, Dr. Chul Kim is joined by Dr. Hye-Ryun Kim and...

The Global Fight Against Lung Cancer: A Conversation with WHO's José Luis Castro

Aug 25, 2026 - 00:29:24

Host Dr. Stephen Liu is joined by José Luis Castro, WHO Director-General Special Envoy for Chronic Respir...

LCC: Grace Under Pressure: Navigating Burnout and Loss in Oncology

Aug 18, 2026 - 00:47:14

In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Mark Lewis and Dr. Mi...

Treating Advanced Thymic Cancers

Aug 4, 2026 - 00:59:23

Thymic epithelial tumors are rare but complex thoracic cancers that require specialized diagnosis and mul...

FDA Approval: Zidesamtinib and ROS1 NSCLC

Jul 28, 2026 - 00:24:01

Patients with ROS1-positive NSCLC have a new treatment option following the FDA approval of zidesamtinib...

Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer

Jul 21, 2026 - 00:47:39

How could cellular therapies and cancer vaccines transform the future of treatment for ALK-positive lung...